SAT0086 Receptor Activator of Nuclear Factor Kappa-B Ligand (Rankl) and Sclerostin are Related to Joint Destruction in Early Rheumatoid Arthritis

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 679.3-680
Author(s):  
S. Rantapää-Dahlqvist ◽  
A. Boman ◽  
H. Kokkonen ◽  
E. Berglin
Keyword(s):  
Rheumatoid Arthritis ◽  
Early Rheumatoid Arthritis ◽  
Nuclear Factor Kappa B ◽  
Joint Destruction ◽  
Nuclear Factor ◽  
Nuclear Factor Kappa ◽  
Receptor Activator

scholarly journals An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis

Rheumatology ◽  
2017 ◽  
Vol 56 (12) ◽  
pp. 2190-2196 ◽  
Author(s):  
Linda Johansson ◽  
Lisbeth Ärlestig ◽  
Heidi Kokkonen ◽  
Mikael Brink ◽  
Solbritt Rantapää-Dahlqvist
Keyword(s):  
Rheumatoid Arthritis ◽  
Nuclear Factor Kappa B ◽  
Nuclear Factor ◽  
Nuclear Factor Kappa ◽  
Receptor Activator
Sign in / Sign up

Export Citation Format

Share Document